Trends in Long-Term Survival Following Liver Resection for Hepatic Colorectal Metastases
By M. Choti, J. Sitzmann, M. Tiburi, Wuthi Sumetchotimetha, R. Rangsin, R. Schulick, K. Lillemoe, C. Yeo, John L. Cameron. Annals of Surgery, 2002
1,470 citations recorded by the source corpus.
Subfields: Hepatology, Oncology, Surgery
View Paper: https://www.semanticscholar.org/paper/4d3d8bf527fd6bf94d36fced678051fcb883131f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Oncology
In Surgery
Citations in the corpus
- Rates and Patterns of Recurrence Following Curative Intent Surgery for Colorectal Liver Metastasis: An International Multi-Institutional Analysis of 1669 Patients (2009, background): “In fact, most studies reporting on outcome following surgical management of colorectal metastasis have focused solely on overall survival rather than recurrence.(6,10,12,16) To date, most series on the topic of pattern of recurrence for colorectal metastasis have been limited by small sample sizes.”
- Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases (2004, background): “This higher survival rate than the survival rate reported in large series (33%–36% 5-year survival) examining patients treated from the 1960s through the mid-1990s(4,21,22) likely reflects improvement in patient selection, perioperative and postoperative care, multidisciplinary treatment, and an app”
- Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors (2012, neutral): “14,16 , 17, 23–”
- Chapter 1. General introduction (2015, positive): “The combination of these developments has led to an important progress and has resulted in more patients being considered suitable for liver resection to almost 30% [62].”
- Effect of Surgical Margin Status on Survival and Site of Recurrence After Hepatic Resection for Colorectal Metastases (2005, result): “In conclusion, the 58% 5-year survival rate reported in the current multicenter study confirms the improvement in survival reported in recent single institutional studies.(5,6) It supports the concept of limited negative margin resection in patients with hepatic CRM.”